國家衛生研究院 NHRI:Item 3990099045/4784
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 915436      在线人数 : 1299
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/4784


    题名: Acellular biological tissues loaded with a novel angiogenic agent (ginsenoside Rg1) as a tissue-engineering extracellular matrix
    其它题名: Transactions - 7th World Biomaterials Congress
    作者: Liang, HC;Huang, YC;Chen, CT;Chang, Y;Lai, PH;Sung, HW
    贡献者: Division of Biotechnology and Pharmaceutical Research
    摘要: The study was to in vitro investigate the effects of ginsenoside Rg1, a natural compound extracted from Panax ginseng, on the proliferation of human umbilical vein endothelial cells (HUVEC). Basic fibroblast growth factor (bFGF) was used as a control. Additionally, angiogenesis and tissue regeneration in a genipin-fixed acellular bovine pericardium (ECM) loaded with Rg1 were investigated subcutaneously in a rat model. The ECMs without drug loading or loaded with bFGF were used as controls. The in vitro results revealed that both bFGF and Rg1 significantly induced HUVEC proliferation. The in vivo results obtained at 1-week postoperatively showed that angiogenesis in the ECM was significantly enhanced by bFGF and Rg1. These results indicated that ginsenoside Rg1 may be a new class of angiogenic agent and may be loaded in the ECM for tissue regeneration. Further in vivo study is still underway.
    日期: 2004
    關聯: Transactions - 7th World Biomaterials Congress. 2004:1725.
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=13844299573
    显示于类别:[陳炯東] 會議論文/會議摘要

    文件中的档案:

    没有与此文件相关的档案.



    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈